India cuts drug approval timelines and removes pre-clinical approval requirement
→Drug approvals must complete within 120–150 days
Change
India reduced clinical trial approval timelines to 120–135 days, capped marketing approvals at 150 days and removed mandatory pre-clinical approval.
Why it matters
Regulatory timelines compress significantly, requiring faster dossier preparation and shifting compliance checks into later stages.
Implications
- → Approval timelines shorten — faster market entry
- → Compliance shifts to later stages — regulatory risk redistributes
Unlock the full brief.
Implications — what this forces you to change
Who is affected — which roles and obligations are exposed
What to watch — binding deadlines and enforcement dates
Real-time alerts — delivered the moment a binding change is published
Clarify with AI — turn any brief into a decision for your role
Start free trial
No credit card · $29/month after trial · Active in seconds
Source
View on Economic Times